SYNHSV Trademark

Trademark Overview


On Thursday, June 9, 2022, a trademark application was filed for SYNHSV with the United States Patent and Trademark Office. The USPTO has given the SYNHSV trademark a serial number of 97451225. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2024. This trademark is owned by Replay Holdings, LLC. The SYNHSV trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for gene therapy to treat human diseases and disorders; gene therapy products, namely, pharmaceutical preparations to treat genetic disorders, namely, human diseases and disorders

Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of DNA technology for purposes of providing gene therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy
synhsv

General Information


Serial Number97451225
Word MarkSYNHSV
Filing DateThursday, June 9, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for gene therapy to treat human diseases and disorders; gene therapy products, namely, pharmaceutical preparations to treat genetic disorders, namely, human diseases and disorders
Goods and ServicesScientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of DNA technology for purposes of providing gene therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREPLAY HOLDINGS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NameREPLAY HOLDINGS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NameReplay Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, June 13, 2022NEW APPLICATION ENTERED
Wednesday, June 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 11, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 20, 2023ASSIGNED TO EXAMINER
Tuesday, April 4, 2023NON-FINAL ACTION WRITTEN
Tuesday, April 4, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 6, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED